Literature DB >> 7944877

Regional cerebral blood flow in mood disorders, III. Treatment and clinical response.

M S Nobler1, H A Sackeim, I Prohovnik, J R Moeller, S Mukherjee, D B Schnur, J Prudic, D P Devanand.   

Abstract

BACKGROUND: Global and regional deficits in cerebral blood flow and glucose metabolism have been reported in major depression, but there is limited information on the effects of somatic treatment and clinical recovery on these abnormalities.
METHODS: We assessed cortical blood flow with the xenon 133 technique in depressed patients prior to a course of electroconvulsive therapy (ECT), 30 minutes before and 50 minutes after a single treatment, and during the week following ECT. Acute (preictal and postictal) effects of a single treatment also were studied in manic patients.
RESULTS: In the depressed and manic groups, larger blood flow reductions in the acute period, both globally and in particular patterns of brain regions, were associated with a superior clinical outcome following the treatment course. In depressed patients, similar patterns were observed for the blood flow changes over a full treatment course. Blood flow reductions in anterior cortical regions were strongly associated with a positive clinical response in both depression and mania.
CONCLUSIONS: The findings indicated that cerebral blood flow abnormalities in major depression were not reversed by successful treatment with ECT. Rather, particularly in responders, ECT resulted in additional perfusion reductions. The therapeutic properties of ECT are related to reduced functional brain activity in specific neural regions.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7944877     DOI: 10.1001/archpsyc.1994.03950110044007

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  24 in total

Review 1.  Improvement of depression following transcranial magnetic stimulation.

Authors:  M S George; Z Nahas; F A Kozel; J Goldman; M Molloy; N Oliver
Journal:  Curr Psychiatry Rep       Date:  1999-12       Impact factor: 5.285

Review 2.  Effects of medications on cerebral blood flow in late-life depression.

Authors:  Mitchell S Nobler; Kristian R Olvet; Harold A Sackeim
Journal:  Curr Psychiatry Rep       Date:  2002-02       Impact factor: 5.285

Review 3.  [Adverse cognitive effects and ECT].

Authors:  Michael Prapotnik; Roger Pycha; Csaba Nemes; Peter König; Armand Hausmann; Andreas Conca
Journal:  Wien Med Wochenschr       Date:  2006-04

4.  Long lasting effects of electroconvulsive seizures on brain oxidative parameters.

Authors:  Gustavo Feier; Luciano K Jornada; Tatiana Barichello; Angeles M Vitali; Fernanda Bonatto; José Cláudio F Moreira; Felipe Dal-Pizzol; João Quevedo
Journal:  Neurochem Res       Date:  2006-05-23       Impact factor: 3.996

5.  Decreased creatine kinase activity caused by electroconvulsive shock.

Authors:  Márcio Búrigo; Clarissa A Roza; Cintia Bassani; Gustavo Feier; Felipe Dal-Pizzol; João Quevedo; Emilio L Streck
Journal:  Neurochem Res       Date:  2006-06-21       Impact factor: 3.996

Review 6.  The role of glial adenosine receptors in neural resilience and the neurobiology of mood disorders.

Authors:  Dietrich van Calker; Knut Biber
Journal:  Neurochem Res       Date:  2005-10       Impact factor: 3.996

7.  Effect of electroconvulsive shock on mitochondrial respiratory chain in rat brain.

Authors:  Márcio Búrigo; Clarissa A Roza; Cintia Bassani; Diego A Fagundes; Gislaine T Rezin; Gustavo Feier; Felipe Dal-Pizzol; João Quevedo; Emilio L Streck
Journal:  Neurochem Res       Date:  2006-10-25       Impact factor: 3.996

8.  Modulation of intrinsic brain activity by electroconvulsive therapy in major depression.

Authors:  Amber M Leaver; Randall Espinoza; Tara Pirnia; Shantanu H Joshi; Roger P Woods; Katherine L Narr
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2016-01

9.  A two-site, open-label, non-randomized trial comparing Focal Electrically-Administered Seizure Therapy (FEAST) and right unilateral ultrabrief pulse electroconvulsive therapy (RUL-UBP ECT).

Authors:  Gregory L Sahlem; William V McCall; E Baron Short; Peter B Rosenquist; James B Fox; Nagy A Youssef; Andrew J Manett; Suzanne E Kerns; Morgan M Dancy; Laryssa McCloud; Mark S George; Harold A Sackeim
Journal:  Brain Stimul       Date:  2020-07-29       Impact factor: 8.955

Review 10.  Neural circuitry and neuroplasticity in mood disorders: insights for novel therapeutic targets.

Authors:  Paul J Carlson; Jaskaran B Singh; Carlos A Zarate; Wayne C Drevets; Husseini K Manji
Journal:  NeuroRx       Date:  2006-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.